Display options
Cite
Rai V, Yadav U, Kumar P, et al. Methylenetetrahydrofolate reductase polymorphism is not risk factor for Down syndrome in North India. Indian J Hum Genet. 2014;20(2):142-7doi: 10.4103/0971-6866.142858.
Rai, V., Yadav, U., Kumar, P., & Yadav, S. K. (2014). Methylenetetrahydrofolate reductase polymorphism is not risk factor for Down syndrome in North India. Indian journal of human genetics, 20(2), 142-7. https://doi.org/10.4103/0971-6866.142858
Rai, Vandana, et al. "Methylenetetrahydrofolate reductase polymorphism is not risk factor for Down syndrome in North India." Indian journal of human genetics vol. 20,2 (2014): 142-7. doi: https://doi.org/10.4103/0971-6866.142858
Rai V, Yadav U, Kumar P, Yadav SK. Methylenetetrahydrofolate reductase polymorphism is not risk factor for Down syndrome in North India. Indian J Hum Genet. 2014 Apr;20(2):142-7. doi: 10.4103/0971-6866.142858. PMID: 25400341; PMCID: PMC4228564.
Copy Download .nbib Format: NLM
Share it on

Indian J Hum Genet. 2014 Apr;20(2):142-7. doi: 10.4103/0971-6866.142858.

Methylenetetrahydrofolate reductase polymorphism is not risk factor for Down syndrome in North India.

Indian journal of human genetics

Vandana Rai, Upendra Yadav, Pradeep Kumar, Sushil Kumar Yadav

Affiliations

  1. Department of Biotechnology, Human Molecular Genetics Laboratory, VBS Purvanchal University, Jaunpur, Uttar Pradesh, India.

PMID: 25400341 PMCID: PMC4228564 DOI: 10.4103/0971-6866.142858

Abstract

BACKGROUND: Down syndrome (DS) is the most common cause of mental retardation of genetic etiology with the prevalence rate of 1/700 to 1/1000 live births worldwide. Several polymorphisms in folate/homocysteine metabolism pathways genes have been reported as a risk factor in women for bearing DS child, but very few studies investigated these polymorphisms in DS cases whether there are a risk factor for being DS or not.

OBJECTIVE: We have investigated the association of methylenetetrahydrofolate reductase (MTHFR) with the occurrence of DS in Indian population. MTHFR is one of the key regulatory enzymes involved in the metabolic pathway of homocysteine responsible for the reduction of methyltetrahydrofolate. A total of 32 DS cases and 64 age, sex matched controls were genotyped for MTHFR C677T polymorphism by polymerase chain reaction-restriction fragment length polymorphism.

RESULTS: The observed genotype frequencies were CC = 0.81; CT = 0.17 and TT = 0.02 in controls and CC = 0.81 and CT = 0.19 in DS cases. Frequency of T allele in DS and controls were 0.09 and 0.1, respectively. Significant difference in the distribution of mutant 677T allele was not observed between DS cases and controls (odds ratio = 0.915; 95% confidence intervals: 0.331-2.53; P = 0.864).

CONCLUSION: Results of this study indicate that MTHFR C677T polymorphism is not risk factor for DS.

Keywords: Down syndrome; homocysteine; methylation; methylenetetrahydrofolate reductase; polymorphism

References

  1. J Neurol Neurosurg Psychiatry. 2005 May;76(5):706-9 - PubMed
  2. Arch Neurol. 1995 Apr;52(4):373-8 - PubMed
  3. J Zhejiang Univ Sci B. 2008 Feb;9(2):93-9 - PubMed
  4. Birth Defects Res A Clin Mol Teratol. 2011 Sep;91(9):848-56 - PubMed
  5. Am J Hum Genet. 2000 Sep;67(3):623-30 - PubMed
  6. Indian J Med Sci. 2010 May;64(5):219-23 - PubMed
  7. Am J Med Genet A. 2006 May 1;140(9):987-97 - PubMed
  8. Am J Med Genet A. 2004 May 15;127A(1):5-10 - PubMed
  9. Indian J Hum Genet. 2012 Jan;18(1):43-6 - PubMed
  10. Genet Mol Res. 2010 Jun 22;9(2):1197-203 - PubMed
  11. Am J Hum Genet. 1998 May;62(5):1258-60 - PubMed
  12. Pediatr Int. 2011 Aug;53(4):546-50 - PubMed
  13. Nat Genet. 1995 May;10(1):111-3 - PubMed
  14. Mutat Res. 2001 Apr 18;475(1-2):57-67 - PubMed
  15. Am J Clin Nutr. 2004 Dec;80(6):1551-7 - PubMed
  16. Pediatr Hematol Oncol. 2008 Dec;25(8):744-50 - PubMed
  17. Trends Neurosci. 2003 Mar;26(3):137-46 - PubMed
  18. Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(4):50-4 - PubMed
  19. Prenat Diagn. 2005 Dec;25(13):1196-9 - PubMed
  20. Genet Mol Res. 2008 Jan 22;7(1):33-42 - PubMed
  21. Am J Med Genet A. 2005 Jun 15;135(3):263-7 - PubMed
  22. Mol Genet Metab. 2007 May;91(1):85-97 - PubMed
  23. Am J Med Genet. 2002 Jan 15;107(2):162-8 - PubMed
  24. Am J Med Genet A. 2003 Sep 1;121A(3):219-24 - PubMed
  25. Am J Hum Genet. 2001 Jul;69(1):88-95 - PubMed
  26. J Med Genet. 2003 Aug;40(8):619-25 - PubMed
  27. Am J Med Genet. 2002 Jan 15;107(2):151-5 - PubMed
  28. Am J Clin Nutr. 1999 Oct;70(4):495-501 - PubMed
  29. Am J Med Genet A. 2009 Oct;149A(10):2080-7 - PubMed
  30. Breast Cancer Res Treat. 2008 Dec;112(3):585-93 - PubMed
  31. Birth Defects Res A Clin Mol Teratol. 2011 Jan;91(1):50-60 - PubMed
  32. Am J Hum Genet. 2001 Aug;69(2):434-9 - PubMed
  33. Am J Epidemiol. 2000 May 1;151(9):862-77 - PubMed
  34. J Genet. 2009 Apr;88(1):9-14 - PubMed
  35. Am J Med Genet A. 2006 May 15;140(10):1083-91 - PubMed

Publication Types